120 related articles for article (PubMed ID: 36573560)
1. Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma.
Karthik N; Lee JJH; Soon JLJ; Chiu HY; Loh AHP; Ong DST; Tam WL; Taneja R
J Pathol; 2023 Mar; 259(3):342-356. PubMed ID: 36573560
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
4. The RNA helicase DDX5 cooperates with EHMT2 to sustain alveolar rhabdomyosarcoma growth.
Gualtieri A; Bianconi V; Renzini A; Pieroni L; Licursi V; Mozzetta C
Cell Rep; 2022 Aug; 40(9):111267. PubMed ID: 36044855
[TBL] [Abstract][Full Text] [Related]
5. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
6. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
7. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
8. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.
Lee MH; Jothi M; Gudkov AV; Mal AK
Cancer Res; 2011 Jun; 71(11):3921-31. PubMed ID: 21493592
[TBL] [Abstract][Full Text] [Related]
10. EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma.
Nachiyappan A; Soon JLJ; Lim HJ; Lee VK; Taneja R
J Pathol; 2022 Mar; 256(3):349-362. PubMed ID: 34897678
[TBL] [Abstract][Full Text] [Related]
11. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
12. Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis.
Pande P; Zhong XB; Ku WW
Drug Metab Dispos; 2020 Dec; 48(12):1321-1329. PubMed ID: 33077425
[TBL] [Abstract][Full Text] [Related]
13. The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).
Ciarapica R; De Salvo M; Carcarino E; Bracaglia G; Adesso L; Leoncini PP; Dall'Agnese A; Walters ZS; Verginelli F; De Sio L; Boldrini R; Inserra A; Bisogno G; Rosolen A; Alaggio R; Ferrari A; Collini P; Locatelli M; Stifani S; Screpanti I; Rutella S; Yu Q; Marquez VE; Shipley J; Valente S; Mai A; Miele L; Puri PL; Locatelli F; Palacios D; Rota R
Oncogene; 2014 Aug; 33(32):4173-84. PubMed ID: 24213577
[TBL] [Abstract][Full Text] [Related]
14. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
15. Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.
Chen G; Yu X; Zhang M; Zheng A; Wang Z; Zuo Y; Liang Q; Jiang D; Chen Y; Zhao L; Jiang L; Li D; Liao S
Cytogenet Genome Res; 2019; 158(4):205-212. PubMed ID: 31434093
[TBL] [Abstract][Full Text] [Related]
16. Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.
Hwang S; Kim S; Kim K; Yeom J; Park S; Kim I
BMB Rep; 2020 Nov; 53(11):576-581. PubMed ID: 32684241
[TBL] [Abstract][Full Text] [Related]
17. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
[TBL] [Abstract][Full Text] [Related]
18. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
[TBL] [Abstract][Full Text] [Related]
19. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
[TBL] [Abstract][Full Text] [Related]
20. G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
Huang T; Zhang P; Li W; Zhao T; Zhang Z; Chen S; Yang Y; Feng Y; Li F; Shirley Liu X; Zhang L; Jiang G; Zhang F
Cell Death Dis; 2017 Apr; 8(4):e2726. PubMed ID: 28383547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]